New Products Build on Growing Adoption of SonaCare Medical HIFU Technologies Following a Record 130% Increase in International Sales and a 3X Expansion in International Distributors

CHARLOTTE, N.C., March 14, 2013 - SonaCare Medical, LLC (SonaCare Medical), a leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, will showcase two new HIFU products at the 28th annual European Association of Urology (EAU) Congress, in Milan, Italy, March 15-19, 2013.  (Booth: G02)

Company Renamed to Align with Strategic Technology Vision of Urology Devices Utilizing HIFU to Treat a Range of Urological Indications

CHARLOTTE, N.C. – February 20, 2013 – USHIFU, LLC (US HIFU), a global leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today that it has changed the company's name to SonaCare Medical, LLC (SonaCare Medical). Effective immediately, US HIFU will function as SonaCare Medical and all subsidiaries and operating units, including International HIFU and Focus Surgery, will be rebranded to reflect their relationship to SonaCare Medical.

Growing Interest in Potential of HIFU to Offer an Alternative Treatment for Prostate Cancer Designed to Balance Effectiveness and Quality of Life

Charlotte, N.C. – November 19, 2012 -- The ability for technology from USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, to offer another treatment option for prostate cancer designed to balance treatment effectiveness and quality of life was the focus of several research studies presented recently at the Third International Symposium on Focused Ultrasound.  

Focal Therapy Using Sound Waves to Target Individual Areas of Cancer Shows Promise as Alternative to Traditional Treatments for Prostate Cancer

Charlotte, N.C. – April 17, 2012 -- A new treatment for prostate cancer using high intensity focused ultrasound (HIFU) to deliver focal treatment may provide an alternative to traditional treatment with significantly fewer side effects, according to results from a study published in the current issue of Lancet Oncology (DOI:10.1016/S1470-2045(12)70121-3). Incontinence and erectile dysfunction are common side effects of treatments for localized prostate cancer.

Medical Device Industry Veteran Michael Klein Brings 30 Years of Experience to US HIFU

CHARLOTTE, N.C., January 6, 2012 -- USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies,  appointed Michael Klein as the company's new chief executive officer and member of the board of directors. Mr. Klein brings more than  30  years of experience in oncology and the medical device industry to US HIFU, most recently as president of the radiation oncology division of  Roper Industries, Inc. (NYSE: ROP), a publicly traded, diversified manufacturer of engineered products. US HIFU is backed by an investor syndicate led by Galen Partners, a leading healthcare growth equity and late stage venture capital firm. 

Page 9 of 9

HIFU company

Contact

10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384

info@SonaCareMedical.com

Mon - Fri: 9:00 - 5:00

Latest News

26 September 2017

Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017 CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare...

29 August 2017

CHARLOTTE, N.C., August 30, 2017 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces today the successful collaboration with BK Ultrasound, achieving compatibility...